Ac-QVPLRPMTYK-NH2

Ref. 3D-PP43476

Informação sobre produto

• Nome: Ac-QVPLRPMTYK-NH2
• Sinónimos: Ac-Gln-Val-Pro-Leu-Arg-Pro-Met-Thr-Tyr-Lys-amide

Descrição

Peptide Ac-QVPLRPMTYK-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-QVPLRPMTYK-NH2 include the following: Binding and transport of melanoma-specific antigenic peptides by the transporter associated with antigen processing SA Chang, VG Lacaille, DS Guttoh - Molecular immunology, 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S016158909600082X Identification of HLA-A11-Restricted HIV-1-Specific Cytotoxic Tlymphocyte Epitopes in China S Wang, Y Sun, S Zhai, Y Zhuang, S Zhao - Current HIV , 2007 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/chr/2007/00000005/00000001/art00012 Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis PG Kemps , TC Zondag, EC Steenwijk - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2019.03045/full Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. M DiBrino, KC Parker, J Shiloach - Proceedings of the , 1993 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.90.4.1508 Structures of HLA-A* 1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor L Li, M Bouvier - The Journal of Immunology, 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/172/10/6175/36282 Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. JC Skipper, DJ Kittlesen, RC Hendrickson - (Baltimore, Md.: 1950 , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/157/11/5027/29438 Flow-cytometric determination of peptide-class I complex formation identification of p53 peptides that bind to HLA-A2 HJ Zeh III , GH Leder, MT Lotze, RD Salter, M Tector - Human immunology, 1994 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0198885994901058 An HLA-A* 11: 01-binding neoantigen from mutated NPM1 as target for TCR gene therapy in AML DI van der Lee, G Koutsoumpli, RM Reijmers - Cancers, 2021 - mdpi.comhttps://www.mdpi.com/2072-6694/13/21/5390 The Use of Epstein-Barr Virus-Transformed B Lymphocyte Cell Lines in a Peptide-Reconstitution Assay: Identification of CEA-Related HLA-A* 0301-Restricted AJA Bremers, SH van der Burg - Journal of , 1995 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/abstract/1995/08000/The_Use_of_Epstein_Barr_Virus_Transformed_B.1.aspx

• Marca: Biosynth